Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Vaccination against angiotensi...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Vaccination against angiotensin II reduces day-time ambulatory blood pressure: Results of a randomized placebo-controlled phase IIA study with CYT006-ANGQB
Bibliographic Details
Main Authors:
Tissot, A
,
Maurer, P
,
Nussberger, J
,
Wagner, F
,
Pfister, T
,
Stocker, H
,
Mueller, P
,
Jennings, G
,
Bachmann, M
Format:
Journal article
Published:
2007
Holdings
Description
Similar Items
Staff View
Similar Items
Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study.
by: Tissot, A, et al.
Published: (2008)
CYT006-AngQb, a vaccine against hypertension targeting angiotensin II, reduces early-morning and day-time blood pressure
by: Tissot, A, et al.
Published: (2007)
A double-blind, placebo-controlled phase IIa study investigating CYT003-QbG10 as a novel allergen-independent immunotherapy in patients suffering from grass pollen allergy
by: Senti, G, et al.
Published: (2007)
Preclinical antihypertensive efficacy and immunogenicity in humans of a vaccine against angiotensin II based on virus-like particles (VLPs)
by: Tissot, A, et al.
Published: (2005)
Reply to 'Blood pressure vaccine shot down by safety concerns'.
by: Bachmann, M, et al.
Published: (2006)